JANUMET 500 mg/1

JANUMET 500 mg/1 combines sitagliptin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

JANUMET 500 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. It works by increasing insulin sensitivity and reducing glucose production in the liver. This combination medication is often prescribed alongside diet and exercise to manage blood sugar levels effectively.

Common effects of JANUMET 500 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or upper respiratory infections. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

JANUMET 500 mg/1 should be used with caution in individuals with kidney or liver impairment. It is important to stay hydrated and monitor for signs of dehydration, especially during physical activity or in hot weather. Regular blood sugar monitoring is essential to assess the medication's effectiveness and adjust treatment as needed.

JANUMET 500 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of lactic acidosis. Always inform healthcare providers about all medications and supplements being taken to avoid potential interactions.